X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9629) 9629
Newsletter (496) 496
Newspaper Article (253) 253
Magazine Article (65) 65
Book Chapter (40) 40
Dissertation (11) 11
Publication (6) 6
Book / eBook (4) 4
Book Review (4) 4
Transcript (3) 3
Conference Proceeding (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adalimumab (8870) 8870
humans (6657) 6657
infliximab (4373) 4373
female (3906) 3906
male (3682) 3682
adult (3010) 3010
middle aged (2998) 2998
tumor necrosis factor-alpha - antagonists & inhibitors (2885) 2885
etanercept (2728) 2728
treatment outcome (2408) 2408
rheumatology (2353) 2353
antibodies, monoclonal - therapeutic use (2162) 2162
rheumatoid arthritis (1957) 1957
antirheumatic agents - therapeutic use (1857) 1857
arthritis, rheumatoid - drug therapy (1850) 1850
antibodies, monoclonal, humanized (1688) 1688
therapy (1577) 1577
aged (1450) 1450
psoriasis (1400) 1400
gastroenterology & hepatology (1387) 1387
dermatology (1366) 1366
antibodies, monoclonal, humanized - therapeutic use (1327) 1327
efficacy (1257) 1257
adalimumab - therapeutic use (1208) 1208
rheumatoid-arthritis (1182) 1182
care and treatment (1180) 1180
double-blind (1180) 1180
arthritis (1157) 1157
anti-inflammatory agents - therapeutic use (1065) 1065
methotrexate (1059) 1059
crohn's disease (1056) 1056
severity of illness index (1040) 1040
crohn disease - drug therapy (1024) 1024
safety (1013) 1013
tumor necrosis factor (1008) 1008
antibodies, monoclonal - adverse effects (976) 976
drug therapy (927) 927
immunoglobulin g - therapeutic use (906) 906
receptors, tumor necrosis factor - therapeutic use (905) 905
psoriasis - drug therapy (882) 882
young adult (870) 870
retrospective studies (861) 861
pharmacology & pharmacy (840) 840
antirheumatic agents - adverse effects (837) 837
crohns-disease (804) 804
research (799) 799
inflammatory-bowel-disease (792) 792
inflammatory bowel disease (773) 773
adolescent (741) 741
drug therapy, combination (715) 715
tumor necrosis factor-tnf (704) 704
monoclonal antibodies (693) 693
analysis (677) 677
medicine & public health (660) 660
rheumatoid factor (659) 659
ulcerative colitis (655) 655
patients (641) 641
medical research (625) 625
abridged index medicus (600) 600
methotrexate - therapeutic use (599) 599
disease (595) 595
infliximab - therapeutic use (594) 594
medicine, experimental (581) 581
antibodies, monoclonal, humanized - adverse effects (578) 578
risk factors (563) 563
remission (547) 547
immunosuppressive agents - therapeutic use (543) 543
time factors (531) 531
immunology (530) 530
remission induction (519) 519
follow-up studies (516) 516
prospective studies (514) 514
medicine, general & internal (506) 506
clinical trials (504) 504
monoclonal-antibody (486) 486
certolizumab pegol (471) 471
trial (468) 468
adalimumab - adverse effects (463) 463
inflammation (463) 463
antibodies, monoclonal - administration & dosage (461) 461
biological products - therapeutic use (461) 461
anti-inflammatory agents - adverse effects (446) 446
health aspects (445) 445
arthritis, psoriatic - drug therapy (439) 439
antibodies (436) 436
management (434) 434
biologics (433) 433
immunotherapy (433) 433
dosage and administration (432) 432
psoriatic arthritis (428) 428
anti-tnf (424) 424
quality of life (423) 423
antirheumatic agents - administration & dosage (418) 418
ankylosing spondylitis (415) 415
child (404) 404
tumor necrosis factor-alpha - immunology (404) 404
immunoglobulin g - adverse effects (403) 403
risk (391) 391
biological products (386) 386
necrosis-factor-alpha (382) 382
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9750) 9750
Spanish (204) 204
German (179) 179
French (166) 166
Korean (78) 78
Japanese (77) 77
Portuguese (74) 74
Russian (51) 51
Italian (41) 41
Polish (37) 37
Hungarian (28) 28
Danish (19) 19
Turkish (17) 17
Czech (16) 16
Chinese (12) 12
Croatian (12) 12
Dutch (8) 8
Swedish (5) 5
Norwegian (4) 4
Slovak (4) 4
Finnish (2) 2
Serbian (2) 2
Arabic (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alimentary pharmacology & therapeutics, ISSN 0269-2813, 2017, Volume 46, Issue 9, pp. 873 - 882
Summary Background Significance of monitoring adalimumab trough levels and anti‐adalimumab antibodies (AAA) for disease outcome in Crohn's disease (CD)... 
RHEUMATOID-ARTHRITIS | MAINTENANCE | INFLAMMATORY-BOWEL-DISEASE | 6-THIOGUANINE NUCLEOTIDE | IMMUNOMODULATORS | COMBINATION THERAPY | ULCERATIVE-COLITIS | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-RESPONSE | Guanine Nucleotides - blood | Adalimumab - immunology | Thionucleotides - blood | Humans | Anti-Inflammatory Agents - immunology | Male | Treatment Outcome | Crohn Disease - immunology | Anti-Inflammatory Agents - blood | Adalimumab - therapeutic use | Mercaptopurine - therapeutic use | Adalimumab - blood | Crohn Disease - blood | Crohn Disease - drug therapy | Sensitivity and Specificity | Adalimumab - pharmacokinetics | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Antibodies - blood | Female | Drug Therapy, Combination | Mercaptopurine - analogs & derivatives | Measurement | Viral antibodies | Medical research | Analysis | Medicine, Experimental | Antibodies | Biopharmaceutics | Blood cells | Body weight | Erythrocytes | Diamonds | Crohn's disease | Pharmacology | Regression analysis | Thioguanine | Patients | Crohns disease | Sensitivity | Regression models | Red blood cells | Multiple regression models | Predictions | Monoclonal antibodies | Remission | Pharmacokinetics | Original | Personalised Adalimumab Pharmacokinetics
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 08/2019, Volume 17, Issue 8, pp. 837 - 839
Journal Article
Journal Article
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 11/2013, Volume 13, Issue 11, pp. 1599 - 1611
Introduction: Following its marketing authorization for the treatment of ankylosing spondylitis (AS) in 2006 in the United States und in the European Union,... 
nonradiographic axial spondyloarthritis | tumor necrosis factor α | adalimumab | ankylosing spondylitis | Adalimumab | Nonradiographic axial spondyloarthritis | Ankylosing spondylitis | Tumor necrosis factor α | MEDICINE, RESEARCH & EXPERIMENTAL | FACTOR ANTAGONIST THERAPY | SHORT-TERM IMPROVEMENT | OF-LIFE OUTCOMES | SOCIETY CLASSIFICATION CRITERIA | RADIOGRAPHIC PROGRESSION | RHEUMATOLOGY BIOLOGICS REGISTER | TNF-ALPHA INHIBITORS | tumor necrosis factor alpha | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | OPEN-LABEL TRIAL | PLACEBO-CONTROLLED TRIAL | NECROSIS-FACTOR BLOCKERS | Spondylarthritis - diagnostic imaging | Clinical Trials as Topic - statistics & numerical data | Antirheumatic Agents - administration & dosage | United States | Humans | Spondylarthritis - drug therapy | Spondylarthritis - pathology | Biological Products - pharmacology | Drug Approval | Infection - etiology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacology | Antirheumatic Agents - adverse effects | Biological Products - adverse effects | Antirheumatic Agents - pharmacology | Spine - pathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Antibodies, Monoclonal, Humanized - adverse effects | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Antibodies, Monoclonal, Humanized - therapeutic use | Disease Susceptibility | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Treatment Outcome | Disease Progression | Spondylitis, Ankylosing - diagnostic imaging | Radiography | Spine - diagnostic imaging | European Union | Biological Products - administration & dosage | Spondylitis, Ankylosing - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, ISSN 1173-8804, 2007, Volume 21, Issue 2, pp. 125 - 132
Journal Article